eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2006, Volume 2, Issue 1 : 37-43 doi: ijmmas.2006.37.43
Research Article
Transforming Cellular Roles for Antigen Presentation and Immunoreactivity in Multiple Sclerosis
Published
June 30, 2005
Abstract

A simplified program operative during transition of lymphocytes and monocytes through cerebral endothelium and ependyma might provide an effective mechanism promoting reversal of roles of these two cell types with regard to antigen reactivity and antigen presentation. One might envision a role for the oligodendrocyte that mirror images injury to myelin-invested axons as an initiating mechanism in both presenting antigen and in determining the establishment of endless cycles of amplified demyelination. These appear paradoxically dictated by dynamics of the cyclical remyelination of such initially injured axons. Neuroinflammation with involvement of axons would progress as evolving demyelinative plaques scattered in random fashion in white matter.  Macrophages appear to act as effector cells in demyelination of inflamed regions that propagate lymphocyte-induced effects in antigen presentation and immune response. Antigen presentation is implicated as a mechanism of progression of MS plaques. Demyelination depends on active phagocytosis of myelin lipid, in response to such antigen presentation. Transforming roles of lymphocyte antigen presentation and macrophage reactivity appear central to ongoing demyelination and remyelination cycles superimposed on an inflammatory axonopathy.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Personalized Healthcare Using Genomic Data: Advancing Precision Medicine Through Genomic Innovation
51-55
Community-Based Health Programs and Their Effectiveness: Evaluating Impacts on Population Health Outcomes
13-19
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.